BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24350989)

  • 21. Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats.
    Hertzsch S; Roos A; Wess G
    J Vet Intern Med; 2019 May; 33(3):1242-1250. PubMed ID: 30990935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
    Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
    Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.
    Eggers KM; Lindahl B; Venge P; Lind L
    Int J Cardiol; 2018 Apr; 257():300-305. PubMed ID: 29506712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.
    Pelander L; Häggström J; Ley CJ; Ljungvall I
    J Vet Intern Med; 2017 May; 31(3):805-813. PubMed ID: 28370332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
    Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
    J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats.
    Bijsmans ES; Jepson RE; Wheeler C; Syme HM; Elliott J
    J Vet Intern Med; 2017 May; 31(3):650-660. PubMed ID: 28387019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
    Apple FS; Murakami MM; Pearce LA; Herzog CA
    Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
    Venge P; Arnlöv J; Zethelius B
    Scand J Clin Lab Invest; 2009; 69(3):418-24. PubMed ID: 19221927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy.
    Hanås S; Larsson A; Rydén J; Lilliehöök I; Häggström J; Tidholm A; Höglund K; Ljungvall I; Holst BS
    J Feline Med Surg; 2022 Oct; 24(10):e370-e379. PubMed ID: 36073987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NT-ProBNP and cardiac troponin I in virulent canine babesiosis.
    Lobetti R; Kirberger R; Keller N; Kettner F; Dvir E
    Vet Parasitol; 2012 Dec; 190(3-4):333-9. PubMed ID: 22884910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superiority of high sensitivity cardiac troponin I over NT-proBNP and adiponectin for 7-year mortality in stable patients receiving haemodialysis.
    Iwamura N; Kidoguchi S; Asahi N; Takeda I; Matsuta K; Miyagi K; Iwano M; Miyazaki R; Kimura H
    Sci Rep; 2024 May; 14(1):11488. PubMed ID: 38769120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.
    Wurtinger G; Henrich E; Hildebrandt N; Wiedemann N; Schneider M; Hassdenteufel E
    BMC Vet Res; 2017 Dec; 13(1):394. PubMed ID: 29262821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy.
    van Hoek I; Hodgkiss-Geere H; Bode EF; Hamilton-Elliott J; Mõtsküla P; Palermo V; Pereira YM; Culshaw GJ; Ivanova A; Dukes-McEwan J
    J Vet Intern Med; 2020 Mar; 34(2):591-599. PubMed ID: 32045061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy.
    Sahin I; Gungor B; Ozkaynak B; Uzun F; Küçük SH; Avci II; Ozal E; Ayça B; Cetın S; Okuyan E; Dinckal MH
    Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.
    Pierce KV; Rush JE; Freeman LM; Cunningham SM; Yang VK
    J Vet Intern Med; 2017 May; 31(3):678-684. PubMed ID: 28370373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Serum Symmetric Dimethylarginine Concentration as a Marker for Masked Chronic Kidney Disease in Cats With Hyperthyroidism.
    Peterson ME; Varela FV; Rishniw M; Polzin DJ
    J Vet Intern Med; 2018 Jan; 32(1):295-304. PubMed ID: 29377360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertrophic Cardiomyopathy: The Time-Synchronized Relationship between Ischemia and Left Ventricular Dysfunction Assessed by Highly Sensitive Troponin I and NT-proBNP.
    Rajtar-Salwa R; Gębka A; Dziewierz A; Dimitrow PP
    Dis Markers; 2019; 2019():6487152. PubMed ID: 31320942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic significance of the plasma N-terminal pro-B-type natriuretic Peptide concentration in asymptomatic cats with cardiac enlargement.
    Tominaga Y; Miyagawa Y; Toda N; Takemura N
    J Vet Med Sci; 2011 Aug; 73(8):971-5. PubMed ID: 21467762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.